Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04263259 · ClinicalTrials.gov registry record · NA
Efficacy and Mechanisms of Mobile-Delivered Alcohol Attentional Bias Modification
A NA study of Alcohol; Harmful Use, sponsored by University of New Mexi.
- Completed
- Registry status
- NA
- Development phase
- 31
- Enrollment target
- 2
- Study locations
NCT04263259: Completed NA study of Alcohol; Harmful Use, sponsored by University of New Mexi.
NCT04263259 is a NA study of Alcohol; Harmful Use that has completed, run by University of New Mexi. The registered enrollment target is 31 participants, below the 376-participant average among 9 other Alcohol; Harmful Use trials with a reported enrollment target (92% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04263259, a NA study of Alcohol; Harmful Use, has completed, sponsored by University of New Mexi.
- COMPLETED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
- 2
- Study locations
Study Summary
This study evaluates the efficacy as well as psychological and neurobiological mechanisms of mobile-delivered alcohol attentional bias modification among heavy drinking adults.
Primary Outcome
Number of days of alcohol use during the 4-week ecological momentary assessment period
Conditions Studied
Interventions
- BEHAVIORAL Attentional Bias Modification
Study Locations (2)
New Mexico
- Center on Alcoholism, Substance Abuse, & Addictions - Albuquerque
- Mind Research Network - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2020-01-08 |
| Est. Completion | 2021-08-14 |
| Phase | NA |
What the finished NCT04263259 record still lists
NCT04263259 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 376-participant average among 9 other Alcohol; Harmful Use trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Alcohol; Harmful Use appearing as the primary indexed condition, and to 1 intervention - of which Attentional Bias Modification is the first listed.
NCT04263259 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT04263259 about?
NCT04263259 is a clinical study titled "Efficacy and Mechanisms of Mobile-Delivered Alcohol Attentional Bias Modification". This study evaluates the efficacy as well as psychological and neurobiological mechanisms of mobile-delivered alcohol attentional bias modification among heavy drinking adults.
What is the current status of trial NCT04263259?
This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2020-01-08. Estimated completion is 2021-08-14.
What conditions does trial NCT04263259 study?
This clinical trial studies the following conditions: Alcohol; Harmful Use.
What interventions are being tested in trial NCT04263259?
The interventions under investigation include: Attentional Bias Modification (BEHAVIORAL).
Who is sponsoring clinical trial NCT04263259?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04263259 being conducted?
This trial has 2 study locations across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol; Harmful Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04263259's enrollment target sits among peer trials
31 9th of 9 higher than 1 of 9 other Alcohol; Harmful Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol; Harmful Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sleep as a Mechanism of Change in Alcohol Use
RECRUITING · NA
-
Alcohol and the Social Brain: An Alcohol-Administration Hyperscanning Study Employing a Within-Subject Design
RECRUITING · NA
-
Using CBPR to Engage Hazardous Drinking Women in the HIV Prevention and Care Continuum
ACTIVE NOT RECRUITING · NA
-
Game Plan: Efficacy of a Brief, Web-based Intervention on Alcohol Use and Sexually-transmitted Infections
ACTIVE NOT RECRUITING · NA
-
Development and Pilot Trial of an Intervention to Reduce Disclosure Recipients Negative Social Reactions and Victims Psychological Distress and Problem Drinking
COMPLETED · NA
-
Insomnia Treatment and Problems (the iTAP Study)
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI